SBC Medical Group (NASDAQ:SBC), Inc. is a provider of prescription home medical equipment and related services, specializing in respiratory and sleep therapy solutions. The company develops, sources, and distributes a range of devices designed to support patients with chronic respiratory conditions, sleep apnea and mobility challenges. SBC Medical Group markets its products primarily under the SBC Medical brand, focusing on clinician-prescribed durable medical equipment (DME) integrated with digital monitoring and telehealth support.
The company’s product portfolio includes continuous positive airway pressure (CPAP) and bilevel ventilation systems for sleep-disordered breathing, portable and stationary oxygen concentrators, noninvasive ventilators, suction units and mobility aids. In addition to core devices, SBC Medical Group offers diagnostic and patient-monitoring platforms that enable remote data collection, adherence tracking and virtual care coordination. These solutions aim to enhance patient outcomes and reduce the need for hospital readmissions.
SBC Medical Group serves patients through a network of distribution centers and clinical support teams across the United States and in select European markets. The company collaborates with home health agencies, hospitals and physician practices to ensure seamless delivery, setup and ongoing clinical oversight. Its operations are supported by in-house logistics, customer service and technical support functions, designed to streamline equipment maintenance and warranty management.
Founded with a mission to improve quality of life for individuals with chronic respiratory and sleep disorders, SBC Medical Group emphasizes regulatory compliance, quality assurance and patient education. The company continues to invest in research and development partnerships, pursuing enhancements in device connectivity, data analytics and telehealth integration to meet evolving standards of home-based medical care.
